ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,287.60
      -0.24%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.135
      0.00%
      Bitcoin
      63,273.15
      -0.16%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. CytoMed Therapeutics Ltd (GDTC) Quote

      CytoMed Therapeutics Ltd

      CytoMed Therapeutics Ltd (GDTC)

      NASDAQ
      1.55
      0.00
      (0.00%)
      Closed September 21 4:00PM
      Delayed by 15 minutes
      1.53
      0.00
      (0.00%)
      After Hours: 4:33PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.55
      Bid
      1.32
      Ask
      2.25
      Volume
      468
      1.58 Day's Range 1.58
      1.36 52 Week Range 5.50
      Market Cap
      17.887M
      Previous Close
      1.55
      Open
      1.58
      Last Trade
      1
      @
      1.53
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      69,166
      Shares Outstanding
      11,540,000
      Dividend Yield
      -
      PE Ratio
      -4.33
      Earnings Per Share (EPS)
      -0.36
      Revenue
      518k
      Net Profit
      -4.13M

      About CytoMed Therapeutics Ltd

      CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cytomed.sg.
      Headquarters
      Singapore, Sgp
      Founded
      -
      CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was $1.55. Over the last year, CytoMed Therapeutics shares have traded in a share price range of $ 1.36 to $ 5.50.

      CytoMed Therapeutics currently has 11,540,000 shares outstanding. The market capitalization of CytoMed Therapeutics is $17.89 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -4.33.

      Ask ADVFN Intelligence (AI)

      GDTC Latest News

      More News

      CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

      SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      July 17 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      June 20 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 24 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

      May 23 2024
      Edgar (US Regulatory)

      CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

      SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      March 18 2024
      GlobeNewswire Inc.

      CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

      SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      March 04 2024
      GlobeNewswire Inc.

      Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

      SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      January 29 2024
      GlobeNewswire Inc.

      CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

      CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology PR Newswire SINGAPORE, Dec. 5, 2023 SINGAPORE, Dec. 5, 2023 /PRNewswire/ -- CytoMed...

      December 05 2023
      PR Newswire (US)

      CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

      CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update PR Newswire SINGAPORE, Nov. 17, 2023 Conference call webcast is scheduled for November 22 at 9 a.m...

      November 17 2023
      PR Newswire (US)

      CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

      CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference PR Newswire SINGAPORE, Nov. 14, 2023 SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- CytoMed...

      November 14 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.064.026845637581.491.631.4813081.54257571CS
      4-0.05-3.1251.61.641.3625561.49732376CS
      12-0.48-23.6453201972.032.461.36691662.20058327CS
      26-1.04-40.15444015442.592.60991.36343062.19530684CS
      52-2.08-57.30027548213.635.51.36324692.9851347CS
      156-2.45-61.2549.251.361128904.60891544CS
      260-2.45-61.2549.251.361128904.60891544CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 5.645
      (96.01%)
      		61.39M
      ZJYLJin Medical International Ltd
      $ 3.975
      (50.00%)
      		1.24M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.9001
      (39.43%)
      		78.85k
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      AENTAlliance Entertainment Holding Corporation
      $ 2.74
      (34.31%)
      		4.23M
      GSIWGarden Stage Ltd
      $ 1.34
      (-82.89%)
      		26.44M
      CRBPCorbus Pharmaceuticals Holdings Inc
      $ 19.51
      (-62.26%)
      		12.29M
      LGCBLinkage Global Inc
      $ 0.4183
      (-57.70%)
      		2.16M
      BFIBurgerFi International Inc
      $ 0.0855
      (-42.27%)
      		15.05M
      SKYESkye Bioscience Inc
      $ 3.17
      (-42.26%)
      		5.14M
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      NVDANVIDIA Corporation
      $ 116.00
      (-1.59%)
      		378.16M
      AAPLApple Inc
      $ 228.20
      (-0.29%)
      		320.24M
      INTCIntel Corporation
      $ 21.84
      (3.31%)
      		261.68M
      VERBVerb Technology Company Inc
      $ 0.0742
      (33.45%)
      		178.65M

      GDTC Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      GDTC under $3
      👍️0
      glenn1919 glenn1919 2 months ago
      GDTC.............https://stockcharts.com/h-sc/ui?s=GDTC&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      GDTC under $3
      👍️0
      Awl416 Awl416 7 months ago
      Halt
      👍️0
      Monksdream Monksdream 1 year ago
      GDTC gap fill candidate bears gotta love it
      👍️0
      Eurotradr Eurotradr 1 year ago
      So much further to go. $10 min.
      👍️0
      Monksdream Monksdream 1 year ago
      GDTC No 1 on the early Barchart Top 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      AJ Freely AJ Freely 1 year ago
      $GDTC -Up 300% from yesterdays close
      A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
      Current Price $9.63
      👍️0
      Monksdream Monksdream 1 year ago
      Nurse Sherry bought 100 at $7.50
      👍️0

      Your Recent History

      NASDAQ
      GDTC
      CytoMed Therapeutics
      USOTC
      VMMNF
      Viridis Mining and Miner... (PK)
      Delayed Upgrade Clock